Crown Laboratories Acquires Keri Brand from GlaxoSmithKline
May 1, 2019
Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.
- Buyers
- Crown Laboratories, Inc., Greenspring Associates, Inc., Hildred Capital Partners, LLC, Montreux Equity Partners, LLC
- Targets
- Keri
- Sellers
- GlaxoSmithKline
- Industry
- Consumer Products
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Crown Laboratories Acquires StriVectin from L Catterton
August 26, 2021
Consumer Products
Crown Laboratories, a Hildred Capital portfolio company, has entered into a definitive agreement to acquire StriVectin from L Catterton. StriVectin will operate as a wholly owned subsidiary within Crown's new Premium Skincare Division, with its president Cori Aleardi joining Crown's executive team; the deal was expected to close by mid-September 2021.
-
Crown Laboratories Acquires Xycrobe Therapeutics, Inc.
May 22, 2019
Biotechnology
Crown Laboratories, a privately held skin care company based in Johnson City, Tennessee, has acquired Xycrobe Therapeutics, a developer of skin microbiome-based biotherapeutic technology. Crown plans to integrate Xycrobe’s microbiome platform and scientific team into its R&D organization to expand therapeutic and consumer skin-care capabilities; financial terms were not disclosed.
-
Crown Laboratories Acquires Revance Therapeutics
August 12, 2024
Biotechnology
Crown Laboratories, a Hildred Capital portfolio company, completed the acquisition of Revance Therapeutics through a cash tender offer that expired February 4, 2025; the transaction closed on February 6, 2025 and Revance will be delisted from Nasdaq. The deal brings together Crown's skincare and consumer brands with Revance's DAXXIFY, RHA dermal fillers and other aesthetics/therapeutic offerings to expand product portfolio and commercialization capabilities across medical, retail and e-commerce channels.
-
Crown Capital Investments Acquires KCE, Inc.
February 21, 2020
Trucking & Fleet
Crown Capital Investments, LLC, an Atlanta-based family office, has acquired KCE, Inc., a Glen St. Mary, Florida specialist in oversized load transportation, erosion control and proprietary water cleanup. The acquisition positions Crown Capital to grow KCE ahead of anticipated U.S. infrastructure investment and to optimize the company’s operations and capabilities.
-
Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets
May 24, 2022
Medical Devices
Crown Laboratories has acquired the global, aesthetics-focused assets of Eclipse Medcorp, LLC, expanding Crown's aesthetics product portfolio and integrating Eclipse's devices into its Aesthetics business unit. The deal aims to broaden Crown's product offerings to aesthetics providers domestically and internationally and preserve service and medical-education support for Eclipse customers under Crown.
-
Cerberus Capital Management Acquires Kellermeyer Bergensons Services (KBS) from GI Partners
November 2, 2019
Industrial Services
Cerberus Capital Management has agreed to acquire Kellermeyer Bergensons Services, LLC (KBS) from affiliates of GI Partners. KBS is a North American, technology-enabled provider of integrated facility management services serving industrial, commercial, logistics, retail and grocery customers; the transaction is expected to close in Q4 2019 with terms undisclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.